Tuesday, January 1, 2019

Shilpa Medicare gets USFDA approval for Irinotecan HCL Injection; Stock gains 3%

According to IQVIA MAT Q2 2018 data, the US market for Irinotecan HCL is ~$18mn.

from India Infoline News Service http://bit.ly/2F1wW86
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)